Traders assign a 94.5% implied probability against a new COVID variant of concern before 2027 because global surveillance shows no escalation to VOC status despite ongoing Omicron sublineage circulation. WHO and ECDC tracking as of July 2026 lists only JN.1 as a variant of interest and several sublineages such as NB.1.8.1, XFG, BA.3.2, and PQ.16.1.1 as variants under monitoring, none of which have demonstrated the transmissibility, severity, or immune-escape traits required for higher classification. COVID activity remains low in the United States and many regions through mid-August 2026, with updated 2026-2027 vaccines targeting XFG reflecting gradual evolution rather than disruptive change. Population immunity from prior infections and vaccinations continues to limit the potential for any subvariant to meet VOC criteria in the remaining months of 2026.